Abstract
The trend of postponing pregnancy to older age increases the risk of developing malignancies before fulfilling reproduction plans. A non-negligible number of women who are in their fertile age and still have no children suddenly face a situation of receiving a diagnosis of reproductive organ malignancy.
Protection of fertility in young women is one of the important parts of treatment management. Of foremost importance is the oncological treatment outcome; hence, indications to fertility-sparing management are narrowed down to the population of younger women with early-stage, low-grade tumours who are very strongly motivated.
Fertility-sparing management in gynaecological malignancies is possible, but under precisely defined conditions. Intensive follow-up after completion of conservative treatment is essential for all patients who receive it since the risk of recurrence is real.
The benefits, risks, and safety of treatment should remain balanced.